Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

[Axillary lymph node metastases in breast cancer. Anatomo-clinical correlation and surgical approach].

Coroş MF, Stolnicu S, Georgescu R, Roşca A, Sorlea S, Dobre A, Podeanu D, Pălăsan A, Man C, Turcan C.

Chirurgia (Bucur). 2009 Sep-Oct;104(5):557-64. Romanian.

PMID:
19943554
2.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
3.

Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.

Haigh PI, Hansen NM, Qi K, Giuliano AE.

Ann Surg Oncol. 2000 Jan-Feb;7(1):21-7.

PMID:
10674444
4.

Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.

Changsri C, Prakash S, Sandweiss L, Bose S.

Breast J. 2004 Sep-Oct;10(5):392-7.

PMID:
15327491
5.

Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.

Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.

J Exp Clin Cancer Res. 2000 Jun;19(2):141-4.

PMID:
10965808
6.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
7.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

8.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
9.

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

Chung MH, Ye W, Giuliano AE.

Ann Surg Oncol. 2001 Oct;8(9):688-92.

PMID:
11597008
10.

Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?

Saiz E, Toonkel R, Poppiti RJ Jr, Robinson MJ.

Cancer. 1999 May 15;85(10):2206-11. Review.

PMID:
10326699
11.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035
12.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
13.

Sentinel lymphadenectomy for breast cancer in a community managed care setting.

Guenther JM, Krishnamoorthy M, Tan LR.

Cancer J Sci Am. 1997 Nov-Dec;3(6):336-40.

PMID:
9403045
14.

Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F.

Arch Surg. 2004 Jun;139(6):648-51.

PMID:
15197092
15.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
16.

Value of the sentinel lymph node procedure in patients with large size breast cancer.

Lelievre L, Houvenaeghel G, Buttarelli M, Brenot-Rossi I, Huiart L, Tallet A, Tarpin C, Jacquemier J.

Ann Surg Oncol. 2007 Feb;14(2):621-6. Epub 2006 Nov 12.

PMID:
17103062
17.

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ.

J Natl Cancer Inst. 2006 May 3;98(9):599-609. Erratum in: J Natl Cancer Inst. 2006 Jun 21;98(12):876.

PMID:
16670385
18.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

J Am Coll Surg. 2000 Jul;191(1):1-6; discussion 6-8.

PMID:
10898177
19.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
20.

Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.

Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O'Connell TX.

Arch Surg. 2003 Jan;138(1):52-6.

PMID:
12511150

Supplemental Content

Support Center